Wednesday, July 8, 2026

Drug profile · INN

albumin chromated cr-51 serum

albumin chromated cr-51 serum (CHROMALBIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — albumin chromated cr-51 serum
US status
approved
Class
Route
INJECTION
Patents
0
Programs
5
Data quality
0.84

Quick answer

albumin chromated cr-51 serum (CHROMALBIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN albumin chromated cr-51 serum
Brand CHROMALBIN
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. TED Phase 3 · Takeda · Short Bowel Syndrome
  2. Albumin Paclitaxel Phase 2 · Chinese Academy of · Small Cell Lung Cancer
  3. albumin Approved · Chinese Academy of · Sepsis
  4. Albumin Human Unknown · United Therapeutics Europe · Burn Injury
  5. Albumin paclitaxel/neutrophil drug Unknown · Chinese Academy of · Breast Cancer

Frequently asked questions

What is albumin chromated cr-51 serum?

albumin chromated cr-51 serum (CHROMALBIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for albumin chromated cr-51 serum?

CHROMALBIN is a marketed brand name for albumin chromated cr-51 serum. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of albumin chromated cr-51 serum?

albumin chromated cr-51 serum has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.